PT804251E - Uso de composicoes para formacao de imagens de lago sanguineo e metodo - Google Patents
Uso de composicoes para formacao de imagens de lago sanguineo e metodoInfo
- Publication number
- PT804251E PT804251E PT96919971T PT96919971T PT804251E PT 804251 E PT804251 E PT 804251E PT 96919971 T PT96919971 T PT 96919971T PT 96919971 T PT96919971 T PT 96919971T PT 804251 E PT804251 E PT 804251E
- Authority
- PT
- Portugal
- Prior art keywords
- compositions
- circulation
- mixed micelles
- mri
- physiologically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95810403 | 1995-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT804251E true PT804251E (pt) | 2003-01-31 |
Family
ID=8221760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96919971T PT804251E (pt) | 1995-06-15 | 1996-06-14 | Uso de composicoes para formacao de imagens de lago sanguineo e metodo |
Country Status (13)
Country | Link |
---|---|
US (1) | US5833948A (pt) |
EP (1) | EP0804251B1 (pt) |
JP (1) | JP4335976B2 (pt) |
KR (1) | KR100399712B1 (pt) |
AT (1) | ATE224737T1 (pt) |
AU (1) | AU708328B2 (pt) |
CA (1) | CA2195633C (pt) |
DE (1) | DE69623929T2 (pt) |
ES (1) | ES2180784T3 (pt) |
NO (1) | NO314127B1 (pt) |
PT (1) | PT804251E (pt) |
WO (1) | WO1997000087A1 (pt) |
ZA (1) | ZA965101B (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1297034B1 (it) * | 1997-12-30 | 1999-08-03 | Bracco Spa | Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico |
IT1297035B1 (it) * | 1997-12-30 | 1999-08-03 | Bracco Spa | Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico |
US6342598B1 (en) | 1998-11-26 | 2002-01-29 | Bracco International B.V. | Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
EP2286843A3 (en) | 2000-06-02 | 2011-08-03 | Bracco Suisse SA | Compounds for targeting endothelial cells |
US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US20070128253A1 (en) * | 2005-04-13 | 2007-06-07 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
US20060073197A1 (en) * | 2004-05-20 | 2006-04-06 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
US6803046B2 (en) | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
US20050130892A1 (en) * | 2003-03-07 | 2005-06-16 | Xencor, Inc. | BAFF variants and methods thereof |
US20050221443A1 (en) * | 2003-01-06 | 2005-10-06 | Xencor, Inc. | Tumor necrosis factor super family agonists |
US20060014248A1 (en) * | 2003-01-06 | 2006-01-19 | Xencor, Inc. | TNF super family members with altered immunogenicity |
US7553930B2 (en) * | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
EP1590006B1 (en) | 2003-02-04 | 2010-09-08 | Bracco Suisse SA | Ultrasound contrast agents and process for the preparation thereof |
EP2327723A3 (en) | 2003-10-10 | 2012-06-27 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
CA2547024C (en) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Gas-filled microvesicle assembly for contrast imaging |
US20050152842A1 (en) * | 2003-12-24 | 2005-07-14 | Chun Li | Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent |
CN1960707B (zh) * | 2004-06-03 | 2012-11-14 | 博莱科瑞士股份有限公司 | 用于治疗和/或诊断用途的脂质集合体 |
WO2006018433A1 (en) | 2004-08-18 | 2006-02-23 | Bracco Research Sa | Gas-filled microvesicles composition for contrast imaging |
FR2883562B1 (fr) | 2005-03-24 | 2009-02-27 | Guerbet Sa | Chelates lipophiles et leur utilisation en imagerie |
KR20080009682A (ko) * | 2005-04-01 | 2008-01-29 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 킬레이트제인 폴리(펩티드): 제조 방법과 용도 |
EP1898958A2 (en) * | 2005-05-31 | 2008-03-19 | INBIOS S.r.l. | Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
US20090053197A1 (en) * | 2006-06-14 | 2009-02-26 | Ramaekers Joseph C | Transfer Factor Compositions and Methods |
US9125874B2 (en) | 2007-11-30 | 2015-09-08 | The Ramaekers Family Trust | Administration of transfer factor for improving reproductive health |
US9446156B2 (en) | 2006-09-05 | 2016-09-20 | Bracco Suisse S.A. | Gas-filled microvesicles with polymer-modified lipids |
GB0623838D0 (en) * | 2006-11-29 | 2007-01-10 | Malvern Cosmeceutics Ltd | Novel compositions |
US20090074751A1 (en) * | 2007-09-18 | 2009-03-19 | Ramaekers Nutrition, Inc. | Growth factor fraction compositions and methods |
KR101401217B1 (ko) * | 2007-11-07 | 2014-05-28 | 충남대학교산학협력단 | Pe-dtpa의 새로운 용도 |
US8946148B2 (en) | 2007-11-20 | 2015-02-03 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
EP2278984A4 (en) * | 2007-11-30 | 2013-02-27 | Ramaekers Family Trust | COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY |
SG10201906494PA (en) | 2008-01-30 | 2019-09-27 | Histogen Inc | Extracellular matrix compositions |
CN102341126A (zh) * | 2009-02-13 | 2012-02-01 | 华盛顿大学 | 用于磁共振成像的钆表现脂质纳米颗粒 |
WO2010139003A1 (en) * | 2009-06-01 | 2010-12-09 | Commonwealth Scientific And Industrial Research Organisation | Chelating amphiphiles |
SG10201506443TA (en) | 2010-08-17 | 2015-10-29 | Ambrx Inc | Modified relaxin polypeptides and their uses |
EP2639227A1 (en) | 2012-03-14 | 2013-09-18 | Bracco Imaging S.p.A | A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents |
US10039843B2 (en) | 2012-09-07 | 2018-08-07 | Bracco Imaging S.P.A. | Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI |
US11365229B2 (en) | 2012-09-10 | 2022-06-21 | Xencor, Inc. | Methods of treating neurological diseases |
JP6313329B2 (ja) | 2012-12-21 | 2018-04-18 | ブラッコ・スイス・ソシエテ・アノニムBracco Suisse SA | ガス封入マイクロベシクル |
WO2015119642A1 (en) | 2014-02-10 | 2015-08-13 | The Johns Hopkins University | Low oxygen tension enhances endothelial fate of human pluripotent stem cells |
US10519207B2 (en) | 2015-06-12 | 2019-12-31 | Georgia State University Research Foundation, Inc. | Compositions and methods for treating opioid tolerance |
US11110063B2 (en) | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
US12077780B2 (en) | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5387410A (en) * | 1983-03-18 | 1995-02-07 | Mallinckrodt, Inc. | Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes |
US4728575A (en) * | 1984-04-27 | 1988-03-01 | Vestar, Inc. | Contrast agents for NMR imaging |
US5215680A (en) * | 1990-07-10 | 1993-06-01 | Cavitation-Control Technology, Inc. | Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles |
WO1992021017A1 (en) * | 1991-05-23 | 1992-11-26 | Unger Evan C | Liposoluble compounds for magnetic resonance imaging |
US5464696A (en) * | 1992-08-13 | 1995-11-07 | Bracco International B.V. | Particles for NMR imaging |
US5534241A (en) * | 1993-07-23 | 1996-07-09 | Torchilin; Vladimir P. | Amphipathic polychelating compounds and methods of use |
US5567410A (en) * | 1994-06-24 | 1996-10-22 | The General Hospital Corporation | Composotions and methods for radiographic imaging |
-
1996
- 1996-06-13 US US08/663,545 patent/US5833948A/en not_active Expired - Lifetime
- 1996-06-14 ES ES96919971T patent/ES2180784T3/es not_active Expired - Lifetime
- 1996-06-14 AU AU58431/96A patent/AU708328B2/en not_active Ceased
- 1996-06-14 AT AT96919971T patent/ATE224737T1/de not_active IP Right Cessation
- 1996-06-14 JP JP50285697A patent/JP4335976B2/ja not_active Expired - Fee Related
- 1996-06-14 WO PCT/IB1996/000577 patent/WO1997000087A1/en active IP Right Grant
- 1996-06-14 KR KR1019970700923A patent/KR100399712B1/ko not_active IP Right Cessation
- 1996-06-14 EP EP96919971A patent/EP0804251B1/en not_active Expired - Lifetime
- 1996-06-14 DE DE69623929T patent/DE69623929T2/de not_active Expired - Lifetime
- 1996-06-14 ZA ZA965101A patent/ZA965101B/xx unknown
- 1996-06-14 CA CA002195633A patent/CA2195633C/en not_active Expired - Fee Related
- 1996-06-14 PT PT96919971T patent/PT804251E/pt unknown
-
1997
- 1997-02-13 NO NO19970665A patent/NO314127B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR970704477A (ko) | 1997-09-06 |
JP4335976B2 (ja) | 2009-09-30 |
WO1997000087A1 (en) | 1997-01-03 |
CA2195633C (en) | 2008-09-16 |
US5833948A (en) | 1998-11-10 |
NO314127B1 (no) | 2003-02-03 |
EP0804251A1 (en) | 1997-11-05 |
ES2180784T3 (es) | 2003-02-16 |
AU708328B2 (en) | 1999-08-05 |
DE69623929D1 (de) | 2002-10-31 |
DE69623929T2 (de) | 2003-05-15 |
JPH10504044A (ja) | 1998-04-14 |
KR100399712B1 (ko) | 2004-02-18 |
NO970665L (no) | 1997-04-03 |
AU5843196A (en) | 1997-01-15 |
ATE224737T1 (de) | 2002-10-15 |
EP0804251B1 (en) | 2002-09-25 |
ZA965101B (en) | 1997-01-22 |
NO970665D0 (no) | 1997-02-13 |
CA2195633A1 (en) | 1997-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT804251E (pt) | Uso de composicoes para formacao de imagens de lago sanguineo e metodo | |
IL125895A0 (en) | The use of an image enhancing moiety in the preparation of bioactivated nmr or optical imaging contrat agent from a prodrug | |
WO2003061466A3 (en) | Method and apparatus for evaluation of contrast agent uptake based on derived parametric images | |
ES2152932T3 (es) | Particulas de apatita tratadas para tecnicas de imagen para diagnostico medico. | |
WO2005106522A8 (en) | Continuous moving-table mri involving contrast manipulation and/or update of scanning parameters | |
EP0994352A3 (en) | Contrast agent enhanced magnetic resonance imaging of myocardial tissue | |
Chin et al. | Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants | |
Winn et al. | Individual and combined effects of relaxin, estrogen, and progesterone in ovariectomized gilts. II. Effects on mammary development | |
Tournissac et al. | Cranial window for longitudinal and multimodal imaging of the whole mouse cortex | |
Gorospe et al. | Ewing’s sarcoma of the mandible: radiologic features with emphasis on magnetic resonance appearance | |
NO964501L (no) | Liposomsuspensjoner som blod-pool bildekontrastmidler | |
Kanawaku et al. | High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol | |
Cohen et al. | Magnetic resonance imaging of the efficacy of specific inhibition of 5α‐reductase in canine spontaneous benign prostatic hyperplasia | |
Chhem et al. | Paleoradiology: history and new developments | |
Lutsep et al. | Does reversal of ischemia on diffusion‐weighted imaging reflect higher apparent diffusion coefficient values? | |
Song et al. | In vivo quantification of mandibular bone remodeling and vascular changes in a Wistar rat model: A novel HR-MRI and micro-CT fusion technique | |
Kalat et al. | Internal anatomy of common carp (Cyprinus carpio) as revealed by magnetic resonance imaging | |
CN114848678B (zh) | 龟板在制备治疗脑衰老的药物中的应用 | |
Gates et al. | Neuroimaging of fractureless transforamen magnum penetrating injury of the cerebellum | |
Lewin | Technological innovations and discoveries in the | |
Conlogue et al. | Zoological Specimens | |
Ravsten et al. | Ex vivo Bio-orthogonal MRI imaging–A novel method proposed for metastatic cancer detection | |
Friedrich et al. | Noninvasive diagnosis of acute myocarditis by contrast-enhanced magnetic resonance imaging | |
Sumida et al. | Development of the pineal gland: measurement with MR imaging | |
Heinrich | Effects of high static magnetic fields in magnetic resonance imaging on cognition and sensory perceptions |